Crossmark Global Holdings Inc. Buys New Stake in DuPont de Nemours, Inc. $DD

Crossmark Global Holdings Inc. bought a new stake in shares of DuPont de Nemours, Inc. (NYSE:DD – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 140,283 shares of the basic materials company’s stock, valued at approximately $18,221,000. Crossmark Global Holdings Inc. owned approximately 0.10% of DuPont de Nemours at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. Quadrant Capital Group LLC grew its position in DuPont de Nemours by 230.6% in the 3rd quarter. Quadrant Capital Group LLC now owns 12,791 shares of the basic materials company’s stock valued at $1,661,000 after buying an additional 8,922 shares in the last quarter. Physician Wealth Advisors Inc. raised its position in shares of DuPont de Nemours by 223.1% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 210 shares of the basic materials company’s stock worth $27,000 after buying an additional 145 shares in the last quarter. Nisa Investment Advisors LLC lifted its stake in shares of DuPont de Nemours by 257.8% in the 3rd quarter. Nisa Investment Advisors LLC now owns 172,776 shares of the basic materials company’s stock worth $22,442,000 after acquiring an additional 124,492 shares during the period. Integrated Advisors Network LLC lifted its stake in shares of DuPont de Nemours by 241.9% in the 3rd quarter. Integrated Advisors Network LLC now owns 6,502 shares of the basic materials company’s stock worth $845,000 after acquiring an additional 4,600 shares during the period. Finally, Robeco Institutional Asset Management B.V. lifted its stake in shares of DuPont de Nemours by 16.4% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 971,901 shares of the basic materials company’s stock worth $124,360,000 after acquiring an additional 137,070 shares during the period. Institutional investors and hedge funds own 73.96% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on DD. The Goldman Sachs Group lowered their price objective on shares of DuPont de Nemours from $159.00 to $153.00 and set a “neutral” rating on the stock in a research note on Wednesday, September 30th. JPMorgan Chase & Co. downgraded DuPont de Nemours from an “overweight” rating to a “neutral” rating and cut their target price for the stock from $172.00 to $145.00 in a research report on Friday, October 9th. Royal Bank Of Canada cut their target price on DuPont de Nemours from $176.00 to $160.00 and set an “outperform” rating for the company in a research report on Thursday, October 15th. Citigroup decreased their price target on DuPont de Nemours from $170.00 to $162.00 and set a “buy” rating for the company in a research note on Wednesday, October 7th. Finally, Barclays started coverage on DuPont de Nemours in a research report on Tuesday, October 13th. They set an “overweight” rating and a $156.00 price target on the stock. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $162.00.

View Our Latest Report on DuPont de Nemours

DuPont de Nemours Price Performance

Shares of NYSE DD opened at $134.11 on Thursday. DuPont de Nemours, Inc. has a twelve month low of $99.20 and a twelve month high of $157.98. The company has a current ratio of 2.43, a quick ratio of 1.82 and a debt-to-equity ratio of 0.23. The firm has a 50-day moving average of $132.62 and a two-hundred day moving average of $138.13. The company has a market capitalization of $18.11 billion, a price-to-earnings ratio of 298.08, a PEG ratio of 1.23 and a beta of 1.05.

DuPont de Nemours (NYSE:DD – Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The basic materials company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.76 by $0.12. DuPont de Nemours had a net margin of 0.67% and a return on equity of 6.92%. The company had revenue of $1.82 billion for the quarter, compared to analysts’ expectations of $1.81 billion. During the same quarter in the previous year, the company posted $1.12 EPS. The business’s revenue was up 4.0% compared to the same quarter last year. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. As a group, analysts expect that DuPont de Nemours, Inc. will post 7.25 earnings per share for the current fiscal year.

DuPont de Nemours Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, November 30th will be issued a $0.60 dividend. The ex-dividend date of this dividend is Monday, November 30th. This represents a $2.40 annualized dividend and a dividend yield of 1.8%. DuPont de Nemours’s dividend payout ratio is currently 533.33%.

DuPont de Nemours Company Profile

(Free Report)

DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.

The company’s product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.

Featured Stories

Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DD – Free Report).

Institutional Ownership by Quarter for DuPont de Nemours (NYSE:DD)

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.